Varenne Capital Partners Buys 131,950 Shares in CVS Health

The investment firm now owns 1.9% of the pharmacy operator's stock.

Published on Mar. 4, 2026

Varenne Capital Partners, an investment firm, bought a new position in CVS Health Corporation (NYSE:CVS) in the third quarter, acquiring 131,950 shares of the pharmacy operator's stock valued at approximately $9.95 million. This makes CVS Health the 14th largest position in Varenne Capital Partners' portfolio, accounting for 1.9% of the firm's total holdings.

Why it matters

CVS Health is one of the largest pharmacy chains in the United States, operating over 9,900 retail locations. The company has been expanding its healthcare services beyond just filling prescriptions, including the addition of in-store MinuteClinic medical clinics. Varenne Capital Partners' investment in CVS Health signals the firm's belief in the company's growth potential and diversified healthcare offerings.

The details

According to a recent 13F filing, Varenne Capital Partners purchased 131,950 shares of CVS Health in the third quarter. This represents a new position for the investment firm, which did not previously own any CVS Health stock. The shares were valued at approximately $9.95 million, based on CVS Health's stock price at the time.

  • Varenne Capital Partners made the purchase in the third quarter of 2026.

The players

Varenne Capital Partners

An investment firm that has now acquired a 1.9% stake in CVS Health Corporation.

CVS Health Corporation

A large pharmacy operator in the United States with over 9,900 retail locations and expanding healthcare services.

Got photos? Submit your photos here. ›

The takeaway

Varenne Capital Partners' investment in CVS Health reflects the firm's confidence in the pharmacy operator's ability to continue growing its business and diversifying its healthcare offerings. As CVS Health expands beyond traditional retail pharmacy services, investors will be watching to see if the company can maintain its strong market position and capitalize on emerging opportunities in the evolving healthcare landscape.